EW vs LPX · P/E 47, rev $3.39B vs P/E 64, rev $1.24B
Edwards Lifesciences Corp (EW) versus Louisiana-Pacific Corporation (LPX) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Louisiana-Pacific Corporation (LPX) is a building products & equipment company listed on NYSE.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported LPX revenue for 2026-06-30 was $1.24B. Net income was $53.0M. LPX currently screens at market cap $5.26B and trailing P/E 64.4.
EW currently screens at market cap $49.91B and trailing P/E 46.9. LPX currently screens at market cap $5.26B and trailing P/E 64.4.
Not investment advice. Open the EW and LPX stock pages for the full models.
Not investment advice.